May-Hegglin anomaly in a dog

Veterinary Clinical Pathology

Volumn 40, Issue 2, 2011, Pages 207-214

  Flatland, Bente ^a   Fry, Michael M ^a   Baek, Seung J ^a   Bahn, Jae H ^a   Leblanc, Casey J ^a   Dunlap, John R ^b   Carroll, Roger C ^c   Kosiba, Deborah J ^a   Millsaps, Doris J ^a   Schleis, Stephanie E ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

^c UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

Author keywords

Canine; Macrothrombocytes; MYH9; Neutrophil; Thrombocytopenia

Indexed keywords

MYOSIN HEAVY CHAIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CASE REPORT; DOG; DOG DISEASE; FEMALE; GENETICS; POINT MUTATION; THROMBOCYTE; THROMBOCYTOPENIA; THROMBOELASTOGRAPHY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANIMALS; BLOOD PLATELETS; DOG DISEASES; DOGS; FEMALE; MICROSCOPY, ELECTRON, TRANSMISSION; MYOSIN HEAVY CHAINS; POINT MUTATION; THROMBELASTOGRAPHY; THROMBOCYTOPENIA;

CANIS FAMILIARIS;

EID: 79957919971     PISSN: 02756382     EISSN: 1939165X     Source Type: Journal    
DOI: 10.1111/j.1939-165X.2011.00320.x     Document Type: Article

References (24)

1. Pecci A, Noris P, Invernizzi R, et al. Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disease. Br J Haematol. 2002;117:164-167.
2. Seri M, Pecci A, De Bari F, et al. MYH9-related disease May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine. 2003;82:203-215.
3. Althaus K, Greinacher A. MYH9-related platelet disorders. Semin Thromb Haemost. 2009;35:189-203.
4. Heath KE, Campos-Barros A, Toren A, et al. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. Am J Hum Genet. 2001;69:1033-1045.
5. Sellers JR. Myosins: a diverse superfamily. Biochim Biophys Acta. 2000;1496:3-22.
6. Maupin P, Phillips CL, Adelstein RS, Pollard TD. Differential localization of myosin-II isozymes in human cultured cells and blood cells. J Cell Sci. 1994;107:3077-3090.
7. Pujol-Moix N, Kelley MJ, Hernández A, Muñiz-Diaz E, Español I. Ultrastructural analysis of granulocyte inclusions in genetically confirmed MYH9 disorders. Haematologica. 2004;89:330-337.
8. Chen Z, Naveiras O, Balduini AA, et al. The May-Hegglin anomaly gene MHY9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathway. Blood. 2007;110:171-179.
9. Noris P, Spedini P, Belletti S, Magrini U, Balduini CL. Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly): clinical and laboratory findings. Am J Med. 1998;104:355-360.
10. Greinacher A, Bux J, Kiefel V, White JG, Mueller-Eckhardt C. May-Hegglin anomaly: a rare cause of thrombocytopenia. Eur J Pediatr. 1992;151:668-671.
11. Cabrera JR, Fontan G, Lorente F, Regidor C, Fernandez MN. Defective neutrophil mobility in May-Hegglin anomaly. Br J Haematol. 1981;47:337-343.
12. Brunning RD. Morphologic alterations in nucleated blood and marrow cells in genetic disorders. Hum Pathol. 1970;1:99-124.
13. Godwin HA, Ginsburg AD. May-Hegglin anomaly: a defect in megakaryocyte fragmentation? Br J Haematol. 1974;26:117-128.
14. Canobbio I, Noris P, Pecci A, Balduini CL, Balduini C, Torti M. Altered cytoskeleton organization in May-Hegglin anomaly platelets [Abstract]. Platelets. 2004;15:360.
15. Siddiqui T. Ultrastructure of the May-Hegglin anomaly. J Pak Med Assoc. 1997;47:224-226.
16. Lusher JM, Schneider J, Mizukami I, Evans RK. The May-Hegglin anomaly: platelet function, ultrastructure, and chromosome studies. Blood. 1968;32:950-961.
17. Lusher JM, Barnhart MI. Congenital disorders affecting platelets. Semin Thromb Hemost. 1977;4:123-186.
18. Di Pumpo M, Noris P, Pecci A, et al. Defective expression of GPIb/IX/V complex in platelets from patients with May-Hegglin anomaly and Sebastian syndrome. Haematologica. 2002;87:943-947.
19. Siddiqui T, Lammert N, Danier P, Luke M. Immune thrombocytopenia and May-Hegglin anomaly during pregnancy. J Fla Med Assoc. 1991;78:88-92.
20. Tvedten H, Lilliehöök I, Hillström A, Häggstöm J. Plateletcrit is superior to platelet count for assessing platelet status in Cavalier King Charles Spaniels. Vet Clin Pathol. 2008;37:266-271.
21. Stockham SL, Scott MA. Fundamentals of Veterinary Clinical Pathology. 1st ed. Ames, IA: Blackwell Publishing; 2002;190.
22. Kunishima S, Matsushita T, Kojima T, et al. Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions. J Hum Genet. 2001;46:722-729.
23. Hood JC, Huxtable C, Naito I, Smith C, Sinclair R, Savige J. A novel model of autosomal dominant Alport syndrome in Dalmatian dogs. Nephrol Dial Transplant. 2002;17:2094-2098.
24. O'Leary CA, He X, Bolton JA, Gobe G, Duffy D. Haplotype sharing excludes orthologous COL4A3, COL4A4 or MYH9 loci in hereditary nephritis in bull terriers. Anim Genet. 2008;40:252-253.